Literature DB >> 2843570

Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications.

A E Calogero1, W T Gallucci, P W Gold, G P Chrousos.   

Abstract

To examine whether the hypothalamic corticotropin-releasing hormone (CRH) neuron is regulated by CRH, by products of the proopiomelanocortin (POMC) gene, and/or by glucocorticoids, we used a rat hypothalamic organ culture system in which rat CRH secretion from single explanted hypothalami was evaluated by an RIA (iCRH) specific for rat CRH. The effects of graded concentrations of ovine CRH (oCRH), adrenocorticotropin hormone (ACTH), beta-endorphin (beta-EP), alpha-melanocyte-stimulating hormone (alpha-MSH), corticotropin-like intermediate lobe peptide (CLIP), ovine beta-lipotropin (ovine beta-LPH), and dexamethasone (DEX) upon unstimulated and serotonin- (5HT), acetylcholine- (ACh), and norepinephrine-(NE) stimulated CRH secretion were determined. oCRH and DEX inhibited unstimulated iCRH secretion with ID50 at the 10(-8) M range. ACTH had no detectable suppressive effect at 10(-8) M. oCRH, ACTH, and DEX inhibited 5HT-, ACh-, and NE-stimulated iCRH secretion in a dose-dependent fashion. beta-EP, alpha-MSH, and CLIP also inhibited 5HT-induced iCRH secretion. Of the latter peptides, the strongest inhibitor was beta-EP and the weakest was CLIP. Ovine beta-LPH had only a weak inhibitory effect on 5HT-induced iCRH secretion. Generally, the concentrations required for 50% suppression of neurotransmitter-stimulated iCRH secretion were significantly lower than those required for a similar suppression of unstimulated iCRH secretion. In conclusion, these data suggest the presence of multiple negative feedback loops involved in the regulation of the hypothalamic CRH neuron: an ultrashort CRH-mediated loop, a short, hypothalamic POMC-derived peptide loop, and a long, glucocorticoid-mediated negative feedback loop. The potency of these negative feedback loops may be determined by the state of activation of the CRH neuron.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843570      PMCID: PMC303581          DOI: 10.1172/JCI113677

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  68 in total

1.  EFFECT OF INTRACEREBRAL IMPLANTATION OF HYDROCORTISONE ON ADRENOCORTICAL SECRETION AND ADRENAL WEIGHT AFTER UNILATERAL ADRENALECTOMY.

Authors:  B BOHUS; E ENDROECZI
Journal:  Acta Physiol Acad Sci Hung       Date:  1964

2.  Ultrashort-loop positive feedback of corticotropin (ACTH)-releasing factor to enhance ACTH release in stress.

Authors:  N Ono; J C Bedran de Castro; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

3.  Localization and specificity of corticosteroid "feedback receptors" at the hypothalamo-hypophyseal level; comparative effects of various steroids implanted in the median eminence or the anterior pituitary of the rat.

Authors:  B Bohus; D Strashimirov
Journal:  Neuroendocrinology       Date:  1970       Impact factor: 4.914

4.  The action of dexamethasone and vasopressin on hypothalamic CRF production and release.

Authors:  G A Hedge; P G Smelik
Journal:  Neuroendocrinology       Date:  1969       Impact factor: 4.914

5.  Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus.

Authors:  P E Sawchenko
Journal:  Brain Res       Date:  1987-02-17       Impact factor: 3.252

6.  The distribution and cells of origin of ACTH(1-39)-stained varicosities in the paraventricular and supraoptic nuclei.

Authors:  P E Sawchenko; L W Swanson; S A Joseph
Journal:  Brain Res       Date:  1982-01-28       Impact factor: 3.252

7.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

8.  Effect of dexamethasone on immunoreactive corticotropin-releasing factor in the rat median eminence and intermediate-posterior pituitary.

Authors:  T Suda; N Tomori; F Tozawa; T Mouri; H Demura; K Shizume
Journal:  Endocrinology       Date:  1984-03       Impact factor: 4.736

9.  Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study.

Authors:  L W Swanson; P E Sawchenko; J Rivier; W W Vale
Journal:  Neuroendocrinology       Date:  1983       Impact factor: 4.914

10.  Effects of opioid peptides on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro.

Authors:  F Yajima; T Suda; N Tomori; T Sumitomo; Y Nakagami; T Ushiyama; H Demura; K Shizume
Journal:  Life Sci       Date:  1986-07-14       Impact factor: 5.037

View more
  19 in total

Review 1.  Understanding endorphins and their importance in pain management.

Authors:  Adam S Sprouse-Blum; Greg Smith; Daniel Sugai; F Don Parsa
Journal:  Hawaii Med J       Date:  2010-03

2.  Organization and Integration of the Endocrine System.

Authors:  George P Chrousos
Journal:  Sleep Med Clin       Date:  2007-06

3.  Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro.

Authors:  A E Calogero; W T Gallucci; G P Chrousos; P W Gold
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

4.  Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats.

Authors:  T S Huang
Journal:  J Endocrinol Invest       Date:  1997 Jul-Aug       Impact factor: 4.256

5.  A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats.

Authors:  E M Sternberg; W S Young; R Bernardini; A E Calogero; G P Chrousos; P W Gold; R L Wilder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

6.  Liver X receptors regulate adrenal cholesterol balance.

Authors:  Carolyn L Cummins; David H Volle; Yuan Zhang; Jeffrey G McDonald; Benoît Sion; Anne-Marie Lefrançois-Martinez; Françoise Caira; Georges Veyssière; David J Mangelsdorf; Jean-Marc A Lobaccaro
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

7.  EVALUATION OF PLASMA SUBSTANCE P AND BETA-ENDORPHIN LEVELS IN CHILDREN WITH PRADER-WILLI SYNDROME.

Authors:  M G Butler; T A Nelson; D J Driscoll; A M Manzardo
Journal:  J Rare Disord       Date:  2015-09

Review 8.  Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression.

Authors:  B Dubrovsky
Journal:  J Psychiatry Neurosci       Date:  1993-01       Impact factor: 6.186

9.  Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat.

Authors:  A E Calogero; C Liapi; G P Chrousos
Journal:  J Endocrinol Invest       Date:  1991-04       Impact factor: 4.256

10.  Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis.

Authors:  L J Crofford; H Sano; K Karalis; E L Webster; E A Goldmuntz; G P Chrousos; R L Wilder
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.